Energy & Commerce’s Health Counsel Cohen Is Long-Time Industry Advocate
This article was originally published in The Gray Sheet
Executive SummaryHoward Cohen is returning to the House Energy and Commerce Committee as chief health counsel after a decade as a Washington lobbyist, where his clients included biopharmaceutical and medical device makers as well as private insurance firms, hospitals and other health care providers.
You may also be interested in...
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”
CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.